Jeffrey Eisele - 28 Jan 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Exec VP, Program Team Lead
Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Issuer symbol
APLS
Transactions as of
28 Jan 2022
Net transactions value
-$16,748
Form type
4
Filing time
01 Feb 2022, 17:09:05 UTC
Previous filing
25 Jan 2022
Next filing
23 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $16,748 -434 -1.3% $38.59 32,989 28 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.